Department of Anesthesiology
[ Author(Asc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
K
Kowal J, Biyani N, Chami M, Scherer S, Rzepiela AJ, Baumgartner P, Upadhyay V, Nimigean CM, Stahlberg H.  2018.  High-Resolution Cryoelectron Microscopy Structure of the Cyclic Nucleotide-Modulated Potassium Channel MloK1 in a Lipid Bilayer.. Structure. 26(1):20-27.e3.
Kowal J, Chami M, Baumgartner P, Arheit M, Chiu P-L, Rangl M, Scheuring S, Schröder GF, Nimigean CM, Stahlberg H.  2014.  Ligand-induced structural changes in the cyclic nucleotide-modulated potassium channel MloK1.. Nat Commun. 5:3106.
Kopman AF, Lien CA, Naguib M.  2010.  Determining the potency of neuromuscular blockers: are traditional methods flawed? Br J Anaesth. 104(6):705-10.
Kopman AF, Klewicka MM, Kopman DJ, Neuman GG.  1999.  Molar potency is predictive of the speed of onset of neuromuscular block for agents of intermediate, short, and ultrashort duration.. Anesthesiology. 90(2):425-31.
Kopman AF, Lien CA, Naguib M.  2011.  Neuromuscular dose-response studies: determining sample size.. Br J Anaesth. 106(2):194-8.
Kopman AF, Kopman DJ, Ng J, Zank LM.  2005.  Antagonism of profound cisatracurium and rocuronium block: the role of objective assessment of neuromuscular function.. J Clin Anesth. 17(1):30-5.
Kopman AF, Kopman DJ.  2006.  An analysis of the TOF-watch algorithm for modifying the displayed train-of-four ratio.. Acta Anaesthesiol Scand. 50(10):1313-4.
Kong XB, Rubin L, Chen LI, Ciszewska G, Watanabe KA, Tong WP, Sirotnak FM, Chou TC.  1992.  Topoisomerase II-mediated DNA cleavage activity and irreversibility of cleavable complex formation induced by DNA intercalator with alkylating capability.. Mol Pharmacol. 41(2):237-44.
Kollef MH, Skubas NJ, Sundt TM.  1999.  A randomized clinical trial of continuous aspiration of subglottic secretions in cardiac surgery patients.. Chest. 116(5):1339-46.
Klemperer JD, Klein I, Gomez M, Helm RE, Ojamaa K, Thomas SJ, Isom OW, Krieger K.  1995.  Thyroid hormone treatment after coronary-artery bypass surgery.. N Engl J Med. 333(23):1522-7.
Klein AA, Skubas NJ, Ender J.  2014.  Controversies and complications in the perioperative management of transcatheter aortic valve replacement.. Anesth Analg. 119(4):784-98.
Kjaer K.  2021.  Quality Assurance and Quality Improvement in the Labor and Delivery Setting.. Anesthesiol Clin. 39(4):613-630.
Kjaer K, Comerford M, Kondilis L, DiMaria L, Abramovitz S, Kiselev M, Samuels J, Gadalla F, Leighton BL.  2006.  Oral sodium citrate increases nausea amongst elective Cesarean delivery patients.. Can J Anaesth. 53(8):776-80.
Kjaer K, Comerford M, Gadalla F.  2004.  General anesthesia for cesarean delivery in a patient with paroxysmal nocturnal hemoglobinuria and thrombocytopenia.. Anesth Analg. 98(5):1471-2,tableofcontents.
Kitz R, Savarese JJ.  1971.  [Progress in the development of new neuromuscular blocking agents].. Rev Bras Anestesiol. 21(4):670-80.
Kitpanit N, Ellozy SH, Connolly PH, Agrusa CJ, Lichtman AD, Schneider DB.  2020.  Risk Factors for Spinal Cord Injury and Complications of Cerebrospinal Fluid Drainage in Patients Undergoing Fenestrated and Branched Endovascular Aneurysm Repair.. J Vasc Surg.
Kisovec M, Rezelj S, Knap P, Cajnko MMojca, Caserman S, Flašker A, Žnidaršič N, Repič M, Mavri J, Ruan Y et al..  2017.  Engineering a pH responsive pore forming protein.. Sci Rep. 7:42231.
Kisor DF, Schmith VD, Wargin WA, Lien CA, Ornstein E, Cook DR.  1996.  Importance of the organ-independent elimination of cisatracurium.. Anesth Analg. 83(5):1065-71.
Kisilevsky A, Gelb AW, Bustillo M, Flexman AM.  2018.  Anaemia and red blood cell transfusion in intracranial neurosurgery: a comprehensive review.. Br J Anaesth. 120(5):988-998.
Kisilevsky A, Gelb AW, Bustillo M, Flexman AM.  2018.  Response to: 'Patient blood management in intracranial neurosurgery-do we have sufficient data to define a transfusion threshold?' (Br J Anaesth 2018; 121: 974-76). Br J Anaesth. 121(4):976-977.
King MM, Huang CY, Chock PB, Nairn AC, Hemmings HC, Chan KF, Greengard P.  1984.  Mammalian brain phosphoproteins as substrates for calcineurin.. J Biol Chem. 259(13):8080-3.
Kim SHyun, Ryan TA.  2013.  Balance of calcineurin Aα and CDK5 activities sets release probability at nerve terminals.. J Neurosci. 33(21):8937-50.
Kim J-H, Pandit N, Yoo M, Park THyun, Choi JU, Park CHoon, Jung K-Y, Lee BIl.  2023.  Crystal structure of [1,2,4]triazolo[4,3-b]pyridazine derivatives as BRD4 bromodomain inhibitors and structure-activity relationship study.. Sci Rep. 13(1):10805.
Kim DM, Nimigean CM.  2016.  Voltage-Gated Potassium Channels: A Structural Examination of Selectivity and Gating.. Cold Spring Harb Perspect Biol. 8(5)
Kim SHyun, Ryan TA.  2009.  Synaptic vesicle recycling at CNS snapses without AP-2.. J Neurosci. 29(12):3865-74.